Tuesday, November 18, 2008: 10:10 AM
Room 109-B (Pennsylvania Convention Center)
In the pharmaceutical industry, it has been a tradition to deal with the active ingredient (API) and the formulation (drug product, DP) separately.
As a consequence, large amounts of efforts have been devoted to designing in the desired properties of the API through particle engineering techniques.In addition, the linkage of API properties to the performance of the DP has been a holy grail for many of us in the industry. However, some of the desired properties of the API can be obtained by simply moving the boundary between API and DP. Some of the approaches that can improve density, material flow, solubility, stability and other properties will be reviewed. We hope to provoke some discussion of perceived obstacles to this approach.
See more of this Session: Quality by Design- Invited Talks and Round Table Discussion
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division
See more of this Group/Topical: Food, Pharmaceutical & Bioengineering Division
![[ Visit Client Website ]](images/banner.gif)